Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ketteler

Showing results (141-150 of 220) with videos related to

Pageof 22
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 21, 2011
Bone alkaline phosphatase and mortality in dialysis patientsChristiane Drechsler, Marion Verduijn, Stefan Pilz, et al.
Kidney International|March 21, 2014
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsJürgen Floege, Adrian C Covic, Markus Ketteler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 25, 2022
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trialMarkus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, et al.
Kidney International. Supplement|April 16, 2003
Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremiaMarkus Ketteler, Christoph Wanner, Thomas Metzger, et al.
Lancet (London, England)|March 19, 2003
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional studyMarkus Ketteler, Philipp Bongartz, Ralf Westenfeld, et al.
Drug Design, Development and Therapy|August 9, 2013
Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitisWolfgang Hohenforst-Schmidt, Arndt Petermann, Aikaterini Visouli, et al.
Thrombosis and Haemostasis|February 5, 2009
Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patientsEllen C M Cranenburg, Vincent M Brandenburg, Cees Vermeer, et al.
Kidney International Reports|December 11, 2020
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO TrialPaolo Raggi, Antonio Bellasi, Smeeta Sinha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 9, 2021
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO StudyDavid A Bushinsky, Paolo Raggi, Jordi Bover, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2013
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney FoundationGeoffrey A Block, Joachim H Ix, Markus Ketteler, et al.
Pageof 22

Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Clinical Journal of the American Society of Nephrology : CJASN|May 21, 2011
Bone alkaline phosphatase and mortality in dialysis patientsChristiane Drechsler, Marion Verduijn, Stefan Pilz, et al.
Kidney International|March 21, 2014
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsJürgen Floege, Adrian C Covic, Markus Ketteler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 25, 2022
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trialMarkus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, et al.
Kidney International. Supplement|April 16, 2003
Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremiaMarkus Ketteler, Christoph Wanner, Thomas Metzger, et al.
Lancet (London, England)|March 19, 2003
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional studyMarkus Ketteler, Philipp Bongartz, Ralf Westenfeld, et al.
Drug Design, Development and Therapy|August 9, 2013
Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitisWolfgang Hohenforst-Schmidt, Arndt Petermann, Aikaterini Visouli, et al.
Thrombosis and Haemostasis|February 5, 2009
Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patientsEllen C M Cranenburg, Vincent M Brandenburg, Cees Vermeer, et al.
Kidney International Reports|December 11, 2020
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO TrialPaolo Raggi, Antonio Bellasi, Smeeta Sinha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 9, 2021
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO StudyDavid A Bushinsky, Paolo Raggi, Jordi Bover, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2013
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney FoundationGeoffrey A Block, Joachim H Ix, Markus Ketteler, et al.
Pageof 22